JACOBS LEVY EQUITY MANAGEMENT, INC
Position in RIGL — Rigel Pharmaceuticals Inc
CIK 884414
FLORHAM PARK, NJ
Position in RIGL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$801,952
-$1,103,426 QoQ
Shares Held
29,658
-33.3% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,503 | $159,939,880 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,939,719 | $98,157,217 | |
| 3 | INCY |
Incyte Corp
|
731,774 | $82,953,900 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
695,532 | $60,476,507 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
322,377 | $25,232,447 | |
| 6 | EXEL |
Exelixis, Inc.
|
415,650 | $22,615,516 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,231,516 | $20,898,826 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
60,986 | $18,358,615 |
All Filings in RIGL
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $801,952 | 29,658 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,905,378 | 44,487 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,437,634 | 50,746 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $4,038,806 | 215,633 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,917,790 | 217,776 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,399,136 | 202,089 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,869,361 | 177,340 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,958,439 | 238,253 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,388,588 | 2,289,587 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,892,123 | 2,684,223 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,638,602 | 3,369,076 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $4,606,797 | 3,571,161 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,981,060 | 3,773,531 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,483,708 | 4,322,472 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,492,801 | 2,960,001 | Shares | Sole | 2022-11-15 | |
| 2020-09-30 | $106,514 | 44,381 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,572,947 | 1,405,982 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,277,299 | 818,782 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||